Related Experiment Videos
Metoclopramide infusion with a disposable portable pump
Annals of Internal Medicine
|June 1, 1986
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Benralizumab: A novel treatment for the cutaneous features of paediatric eosinophilic granulomatosis with polyangiitis (pEGPA).
The Australasian journal of dermatology·2023
Colony housing promotes structural and functional changes during surgically induced osteoarthritis in rats.
Osteoarthritis and cartilage open·2022
The role of empathic nursing telephone interventions with advanced cancer patients: A qualitative study.
European journal of oncology nursing : the official journal of European Oncology Nursing Society·2020
Insulin resistance and body composition in cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology·2020
Improvement of medical judgments by numerical training in patients with multiple sclerosis.
European journal of neurology·2018
In noncardioembolic ischemic stroke or high-risk TIA, asundexian reduced ischemic stroke and did not increase major bleeding.
Annals of internal medicine·2026
Public Policy Approaches to Addressing Adult Obesity: A Position Paper From the American College of Physicians.
Annals of internal medicine·2026
In alcohol use disorder and comorbid obesity, weekly semaglutide reduced heavy drinking days at 26 wk.
Annals of internal medicine·2026
Gastrointestinal In Situ Self-Assembled Gastrodia Elata Polysaccharide Hydrogel Enables Parkinson's Disease Therapy via Gut-Brain Axis Modulation.
Small (Weinheim an der Bergstrasse, Germany)·2026
Efficacy and Cardiovascular Safety of Pegmolesatide in Patients with Anemia of Chronic Kidney Disease: Post hoc Analysis of Two Phase 3 Randomized Trials.
Kidney diseases (Basel, Switzerland)·2026
Sustained-release local anesthetics: advances in drug delivery systems for prolonged postoperative analgesia.
Anesthesia and pain medicine·2026
Evaluating Zasocitinib as an oral therapy for moderate to severe plaque Psoriasis.
Expert opinion on pharmacotherapy·2026